Search references for SB 408124. Phrases containing SB 408124
See searches and references containing SB 408124!SB 408124
Chemical compound
SB-408124 is a drug which is a non-peptide antagonist selective for the orexin receptor subtype OX1, with around 70x selectivity for OX1 over OX2 receptors
SB-408124
Medication
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Oveporexton
Class of drugs
antagonist SB-334867 – first non-peptide selective OX1 antagonist – has been shown to produce sedative and anorectic effects in animals SB-408124 – selective
Orexin_antagonist
Chemical compound
SB-334867 is an orexin antagonist. It was the first non-peptide antagonist developed that is selective for the orexin receptor subtype OX1, with around
SB-334867
Experimental anti-insomnia drug
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Seltorexant
Chemical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Lemborexant
Chemical compound
SB-649868 is a dual orexin receptor antagonist that was being developed by GlaxoSmithKline as a treatment for insomnia. A phase I clinical trial evaluated
SB-649868
Orexin antagonist compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Almorexant
Pharmaceutical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Balumorexton
G-protein-coupled receptor
RTIOX-276 – selective OX1 receptor antagonist SB-334867 – selective OX1 receptor antagonist SB-408124 – selective OX1 receptor antagonist Seltorexant
Orexin_receptor
Chemical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Vornorexant
Chemical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Danavorexton
Orexin receptor antagonist
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Fazamorexant
Pharmaceutical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Cleminorexton
Medication used to treat insomnia
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Daridorexant
Pharmaceutical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Rocavorexant
Novel chemistry compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Alixorexton
Neuropeptide that regulates arousal, wakefulness, and appetite
example, blocking the orexin-1 receptor with the selective orexin antagonist SB-334,867 reduced nicotine self-administration in rats; this may explain why
Orexin
Stimulating neuropeptide
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Orexin-A
Pharmaceutical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Ledasorexton
Chemical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Tebideutorexant
Chemical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
ACT-335827
Protein-coding gene in the species Homo sapiens
approximately 5- to 10-fold selectivity for the OX2 receptor over the OX1 receptor SB-668875 – selective OX2 receptor agonist Suntinorexton – selective OX2 receptor
Orexin_receptor_type_2
Chemical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
EMPA_(drug)
Medication used to treat insomnia
doi:10.1002/ana.26641. PMC 10330114. PMID 36897120. S2CID 257444346. Schipper SB, Van Veen MM, Elders PJ, van Straten A, Van Der Werf YD, Knutson KL, et al
Suvorexant
Chemical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Firazorexton
Chemical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Suntinorexton
Chemical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
JNJ-10397049
Filorexant Lemborexant Nemorexant RTIOX-276 SB-334867 SB-408124 SB-649868 Suvorexant TCS-1102 Agonists: Orexin (A, B) SB-668875 Antagonists: ACT-335827 ACT-462206
List of signaling peptide/protein receptor modulators
List_of_signaling_peptide/protein_receptor_modulators
Chemical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
ACT-462206
Protein-coding gene in the species Homo sapiens
RTIOX-276 - selective OX1 antagonist SB-334,867 - selective OX1 antagonist SB-408,124 - selective OX1 antagonist SB-649,868 - dual OX1 and OX2 antagonist
Hypocretin (orexin) receptor 1
Hypocretin_(orexin)_receptor_1
Chemical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Nivasorexant
Chemical compound
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
Filorexant
Orexin antagonist
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
RTIOX-276
Orexin antagonist
Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102
TCS-OX2-29
SB 408124
SB 408124
SB 408124
SB 408124
SB 408124
SB 408124
SB 408124
SB 408124
SB 408124